A new study conducted by Japanese researchers has found that combining multi-peptide vaccination therapy with the low-dose steroid drug dexamethasone can be effective in treating chemotherapy-naive castration resistant prostate cancer (CRPC) patients. The study, which won the third prize for best abstract in oncology at the 28th European Association of Urology Congress held in Milan, Italy from 15 to 19 March, showed the promising benefit of this combination therapy ...
View the Original article
